Cowen and Company Reaffirms Buy Rating for Heron Therapeutics Inc. (HRTX)

Cowen and Company currently has a $40.00 price objective on the biotechnology company’s stock. A number of other equities analysts also recently¬†…

Advertisements
Cowen and Company Reaffirms Buy Rating for Heron Therapeutics Inc. (HRTX)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s